Manufacturer record

Accura Care Pharmaceuticals Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Accura Care Pharmaceuticals Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between April 2023 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to Accura Care Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2023 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2023
5
Products affected
Dissolution
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2023 · 22025 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Terbinafine Hydrochloride Tablets IP 250mg AT25110990AMfg 2025-11 · Exp 2027-10 DissolutionDissolution Drugs Testing Laboratory, Chennai-06State lab Jul 2026
Ranitidine Oral Solution IP AL24011221DMfg 2024-01 · Exp 2025-12 Content of RanitidineOther SDT&RL, BhubaneswarState lab Nov 2025
Rabicy-20 Tablets Rabeprazole Tablets IP 20 mg AT2403 4149Mfg 2024-03 · Exp 2026-02 NOT OF STANDARD QUALITY &MISBRADED 1. Sample does not complies in respect of Dissolution test as per IP 2. The drug Rabeprazole Sodium is official in IP. But the product titile Rabeprazole Sodium IP is not mentioned on the product label. Hence the subject drug is Misbranded as per section 17 of Drugs & Cosmetics Act 1940, as it is not labeled in the prescribed mannerDissolution State Lab Drugs Control Laboratory, TelanganaState lab Feb 2025
OFLOXACIN & ORNIDAZOLE TABLETS I.P. (OFNI-OZ) AT220708 27Mfg 2022-07 · Exp 2024-06 Dissolution of Ofloxacin and OrnidazoleDissolution RDTL GuwahatiCDSCO lab Jul 2023
FINAVIV-1 Tablets (Finasteride Tablets) AT22070978Mfg 2022-07 · Exp 2024-06 DissolutionDissolution RDTL GuwahatiState lab Apr 2023

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.